Latest Articles
Lo Bosworth Reveals She Had Endometriosis Surgery Just 8 Weeks After Her Fiancé Had Double-Jaw Surgery: 'We've Been Through a Lot' (Exclusive) - MSN
Lo Bosworth Reveals She Had Endometriosis Surgery Just 8 Weeks After Her Fiancé Had Double-Jaw Surgery: 'We've Been Through a Lot' (Exclusive) MSN
Published: Oct. 20, 2025, 11:56 p.m.
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women - VOI.ID
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women VOI.ID
Published: Oct. 20, 2025, 9:35 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal
Published: Oct. 20, 2025, 9:33 p.m.
Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report - Frontiers
Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report Frontiers
Published: Oct. 20, 2025, 9 p.m.
What If We Took Endometriosis as Seriously as We Take Diabetes? - Women's eNews
What If We Took Endometriosis as Seriously as We Take Diabetes? Women's eNews
Published: Oct. 20, 2025, 6:42 p.m.
Celebrities That Have Endometriosis: Halsey, Barbara Palvin, More - Life & Style
Celebrities That Have Endometriosis: Halsey, Barbara Palvin, More Life & Style
Published: Oct. 20, 2025, 6:05 p.m.
Waiting times for endometriosis care 'a catastrophe' says Lothian MP - Edinburgh News
Waiting times for endometriosis care 'a catastrophe' says Lothian MP Edinburgh News
Published: Oct. 20, 2025, 3:57 p.m.
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0
Published: Oct. 20, 2025, 3:54 p.m.
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma - Barchart.com
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma Barchart.com
Published: Oct. 20, 2025, 2:34 p.m.
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider
Published: Oct. 20, 2025, 2:27 p.m.
Link copied to clipboard!